Company Overview
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Company Information
- CEO
- Nicholas Stewart Green MBA
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 371
Contact Information
- Website
- https://www.avidbio.com
- Address
- 2642 Michelle Drive
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 798.90M market capitalization
- Trading Volume: 0 shares traded today
- Price Range: 52-week range of $5.90 - $12.51
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Avid Bioservices, Inc.
Avid Bioservices, Inc. (CDMO) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 798.90M, the company represents a significant player in its market. The stock is currently trading at $12.49 with a positivedaily change of 0.00%.
The company's 371 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -5.18, beta of 1.41, and 52-week price range from $5.90 to $12.51when evaluating investment opportunities.
Why Invest in Avid Bioservices, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Nicholas Stewart Green MBA
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.